IN ⇄ US
ININDIAGLYCO

India Glycols Q1 FY27 results (Apr–Jun 2026) and concall

Fast Moving Consumer Goods · Concall AI · Call held 14 Aug 2026

India Glycols Limited reported a strong Q1 FY27 with a 9% increase in net revenue to INR1,130 crores and a 13% rise in EBITDA to INR170 crores, driven by balanced portfolio performance and improved profitability. The company saw exceptional growth in Ennature Bio Pharma and continued progress in its demerger, while navigating challenges from raw material volatility and freight costs.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

Q1 FY27: revenue up 8.6%, net profit up 45.3% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue961 975 863 1,040 1,091 +14%1,102 +13%978 +13%1,129 +9%
EBITDA116 124 144 148 158 +36%176 +42%164 +14%170 +15%
Net profit39 44 50 53 54 +38%65 +48%110 +120%77 +45%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.